OverviewSuggest Edit

Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD. The Company manufactures and sells a suite of products including the Lightbox imaging console, as well as the Wildcat, Kittycat2, Ocelot family of catheters, and Pantheris. 

TypePublic
Founded2007
HQRedwood City, CA, US
Websiteavinger.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2019)81(+8%)
Revenue (FY, 2019)$9.1 M(+16%)
Share Price (Feb 2021)$1.6 (-3%)
Cybersecurity ratingBMore

Key People/Management at Avinger

Jeffrey M. Soinski

Jeffrey M. Soinski

Chief Executive Officer
Mark Weinswig

Mark Weinswig

Chief Financial Officer
Himanshu Patel

Himanshu Patel

Chief Technology Officer
Corey Gibbs

Corey Gibbs

Vice President, Sales
Phil Preuss

Phil Preuss

Chief Marketing Officer
Thomas Lawson

Thomas Lawson

Vice President, Clinical & Regulatory Affairs
Show more

Avinger Office Locations

Avinger has an office in Redwood City
Redwood City, CA, US (HQ)
600 Chesapeake Dr
Show all (1)

Avinger Financials and Metrics

Avinger Revenue

Embed Graph
View revenue for all periods
Avinger's revenue was reported to be $9.13 m in FY, 2019
USD

Revenue (Q2, 2020)

1.5m

Gross profit (Q2, 2020)

359.0k

Gross profit margin (Q2, 2020), %

24.5%

Net income (Q2, 2020)

(4.0m)

EBIT (Q2, 2020)

(3.6m)

Market capitalization (26-Feb-2021)

151.9m

Closing stock price (26-Feb-2021)

1.6

Cash (30-Jun-2020)

16.6m

EV

149.8m
Avinger's current market capitalization is $151.9 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

10.7m19.2m9.9m7.9m9.1m

Cost of goods sold

6.5m14.4m13.0m6.5m6.3m

Gross profit

4.2m4.8m(3.1m)1.4m2.9m

Gross profit Margin, %

40%25%(31%)17%31%
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

2.1m3.0m2.7m4.5m4.7m5.3m3.5m2.5m2.1m1.8m2.1m2.0m1.8m2.3m2.4m2.3m1.5m

Cost of goods sold

1.3m1.6m1.8m3.4m3.6m3.7m4.1m3.9m3.3m1.4m2.2m1.5m1.5m1.6m1.6m1.8m1.1m

Gross profit

800.0k1.4m971.0k1.2m1.0m1.6m(584.0k)(1.5m)(1.2m)394.0k(111.0k)543.0k373.0k720.0k847.0k501.0k359.0k

Gross profit Margin, %

38%46%36%26%22%30%(17%)(59%)(58%)22%(5%)27%20%31%35%22%24%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

43.1m36.1m5.4m16.4m10.9m

Accounts Receivable

1.6m1.1m1.2m1.5m

Prepaid Expenses

640.0k635.0k311.0k

Inventories

5.4m8.5m4.3m3.4m3.9m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(47.3m)(56.1m)(48.7m)(27.6m)(19.4m)

Depreciation and Amortization

1.3m1.5m1.5m1.3m890.0k

Inventories

(2.3m)(6.1m)(1.2m)(92.0k)(1.2m)

Accounts Payable

84.0k470.0k(334.0k)(125.0k)(485.0k)
USDQ1, 2015

Financial Leverage

1.9 x
Show all financial metrics

Avinger Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Avinger Online and Social Media Presence

Embed Graph

Avinger Company Culture

  • CEO Rating

    C

    70/100

  • Compensation

    D

    55/100

Learn more on Comparably

Avinger News and Updates

Thinking about buying stock in Avinger, Vascular Biogenics, Intra-Cellular Therapies, Agenus, or Co-Diagnostics?

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVGR, VBLT, ITCI, AGEN, and CODX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding...

Thinking about buying stock in 9 Meters Biopharma, Sorrento Therapeutics, Avinger Inc, Delta Air Lines, or TJX Companies?

NEW YORK, Aug. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NMTR, SRNE, AVGR, DAL, and TJX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in NovaBay Pharmaceuticals, RISE Education, eMagin Corp, Avinger Inc, or Clovis Oncology?

NEW YORK, Aug. 18, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NBY, REDU, EMAN, AVGR, and CLVS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $4.…

Avinger to Effect One-for-Ten Reverse Stock Split

REDWOOD CITY, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that the Company will effect a…

Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter
Show more

Avinger Blogs

Study Finds: That Black Men and Women have a 30% Higher Risk for Developing Peripheral Artery Disease

Researchers Quantify the Lifetime Risks of Developing Peripheral Artery Disease Based on Race  

Amputation Awareness Month Awareness Can Save Limbs in Patients with Diabetes and PAD

April is Limb Loss and Amputation Awareness Month. The purpose of this month is celebrating amputees, sharing the realities of what life after a leg amputation is like, and educating the public on the underlying causes of amputations such as Peripheral Artery Disease (PAD). It is importa…

Women More Affected Than Men by Vascular Complications of Diabetes

Women are most affected by the vascular complications of diabetes - a situation likely to escalate in the coming decades, reports an article published in the European Journal of Preventive Cardiology.1

Study Finds: Black Men and Women have a 30% Higher Risk for Developing Peripheral Artery Disease

Researchers Quantify the Lifetime Risk of Developing Peripheral Artery Disease Based on Race

Diabetes: The Problem of Plaque and Peripheral Artery Disease. What Can You Do?

Diabetes already affects over 170 million people worldwide today, and the number of people living with the illness continues to rise. It should reach the threshold of 366 million by 2030.1 Each year, millions of people suffer from the effects of diabetes complications. Foot ulcers, and a…
Show more

Avinger Frequently Asked Questions

  • When was Avinger founded?

    Avinger was founded in 2007.

  • Who are Avinger key executives?

    Avinger's key executives are Jeffrey M. Soinski, Mark Weinswig and Himanshu Patel.

  • How many employees does Avinger have?

    Avinger has 81 employees.

  • What is Avinger revenue?

    Latest Avinger annual revenue is $9.1 m.

  • What is Avinger revenue per employee?

    Latest Avinger revenue per employee is $112.7 k.

  • Who are Avinger competitors?

    Competitors of Avinger include Ra Medical Systems, CardioMech and Pressure BioSciences.

  • Where is Avinger headquarters?

    Avinger headquarters is located at 600 Chesapeake Dr, Redwood City.

  • Where are Avinger offices?

    Avinger has an office in Redwood City.

  • How many offices does Avinger have?

    Avinger has 1 office.